TipRanks
AXIM Biotechnologies Inc (AXIM)
OTHER OTC:AXIM
US Market
AXIM
AXIM Biotechnologies
RESEARCH TOOLSreports

AXIM Biotechnologies (AXIM) Income Statement

151 Followers

AXIM Biotechnologies Income Statement

Last quarter (Q2 2026), AXIM Biotechnologies's total revenue was $206.99K, an increase of Infinity% from the same quarter last year. In Q2, AXIM Biotechnologies's net income was $-188.15K. See AXIM Biotechnologies’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 0.00$ 70.46K$ 39.52K$ 8.88K$ 60.46K
Gross Profit
$ -427.37K$ -369.27K$ 39.52K$ -417.25K$ 60.46K
Operating Expenses
$ 892.28K$ 1.39M$ 2.79M$ 4.66M$ 7.79M
Depreciation and Amortization
$ 427.37K$ 432.39K$ 427.02K$ 426.13K$ 2.12M
EBITDA
$ -892.28K$ -2.44M$ -6.43M$ -3.94M$ -13.17M
Operating Income
$ -1.32M$ -1.76M$ -2.75M$ -4.65M$ -7.99M
Other Income/Expenses
$ 276.57K$ -1.75M$ -5.31M$ -1.59M$ -2.05M
Pretax Income
$ -1.04M$ -3.51M$ -8.06M$ -6.24M$ -16.02M
Net Income
$ -1.04M$ -3.51M$ -8.06M$ -5.96M$ -16.52M
Per Share Metrics
Basic EPS
$ >-0.01$ -0.01$ -0.04$ -0.04$ -0.13
Diluted EPS
$ >-0.01$ -0.01$ -0.04$ -0.04$ -0.13
Weighted Average Shares Outstanding
 340.46M 318.90M 227.69M 165.47M 131.54M
Weighted Average Shares Outstanding (Diluted)
 340.46M 318.90M 227.69M 165.47M 131.54M
Currency in USD

AXIM Biotechnologies Earnings and Revenue History